OBJECTIVE: To assess the status of lipidsoluble antioxidants (carotenoids, tocopherols, ubiquinone), retinol and their correlation with TRAP (total radical-trapping antioxidant potential) in patients with Crohn's disease. DESIGN: Prospective case-control study. SETTING: Clinic of Internal Medicine IV/Department of Gastroenterology and Hepatology, University of Vienna Medical School. SUBJECTS/ METHODS: Plasma antioxidant concentrations were determined in patients with Crohn's disease (n = 24) to evaluate the antioxidant capacity compared to healthy controls (n = 33). Additionally, plasma TRAP (total radical-trapping antioxidant potential) was measured in 13 patients and 22 controls. RESULTS: All investigated carotenoids (alpha-carotene, beta-carotene and cryptoxanthin) were significantly decreased in patients with Crohn's disease (10.2 +/- 9.3, 16.2 +/- 12.4 and 7.8 +/- 5.5 microg/dl) compared to controls (13.3 +/- 5.1, 34.7 +/- 18.8 and 48.5 +/- 38.4 microg/dl respectively), whereas gamma-tocopherol and ubiquinone were significantly elevated in patients (0.14 +/- 0.07 microg/dl and 82.3 +/- 41.5 microg/dl, controls: 0.09 +/- 0.04 microg/dl and 60.8 +/- 30.0 microg/dl, respectively). Retinol and alpha-tocopherol did not significantly differ from controls. The total radical-trapping antioxidant potential (TRAP) was significantly lower in patients (1.11 +/- 0.28 micromol/l) compared to controls (1.34 +/- 0.26 micromol/l). Antioxidants were neither related to duration or severity of disease nor to disease activity. CONCLUSIONS: In patients with Crohn's disease several plasma antioxidant parameters are altered and the total radical-trapping antioxidant potential is decreased.
OBJECTIVE: To assess the status of lipidsoluble antioxidants (carotenoids, tocopherols, ubiquinone), retinol and their correlation with TRAP (total radical-trapping antioxidant potential) in patients with Crohn's disease. DESIGN: Prospective case-control study. SETTING: Clinic of Internal Medicine IV/Department of Gastroenterology and Hepatology, University of Vienna Medical School. SUBJECTS/ METHODS: Plasma antioxidant concentrations were determined in patients with Crohn's disease (n = 24) to evaluate the antioxidant capacity compared to healthy controls (n = 33). Additionally, plasma TRAP (total radical-trapping antioxidant potential) was measured in 13 patients and 22 controls. RESULTS: All investigated carotenoids (alpha-carotene, beta-carotene and cryptoxanthin) were significantly decreased in patients with Crohn's disease (10.2 +/- 9.3, 16.2 +/- 12.4 and 7.8 +/- 5.5 microg/dl) compared to controls (13.3 +/- 5.1, 34.7 +/- 18.8 and 48.5 +/- 38.4 microg/dl respectively), whereas gamma-tocopherol and ubiquinone were significantly elevated in patients (0.14 +/- 0.07 microg/dl and 82.3 +/- 41.5 microg/dl, controls: 0.09 +/- 0.04 microg/dl and 60.8 +/- 30.0 microg/dl, respectively). Retinol and alpha-tocopherol did not significantly differ from controls. The total radical-trapping antioxidant potential (TRAP) was significantly lower in patients (1.11 +/- 0.28 micromol/l) compared to controls (1.34 +/- 0.26 micromol/l). Antioxidants were neither related to duration or severity of disease nor to disease activity. CONCLUSIONS: In patients with Crohn's disease several plasma antioxidant parameters are altered and the total radical-trapping antioxidant potential is decreased.
Authors: Ioannis E Koutroubakis; Niki Malliaraki; Philippos D Dimoulios; Konstantinos Karmiris; Elias Castanas; Elias A Kouroumalis Journal: Dig Dis Sci Date: 2004-09 Impact factor: 3.199
Authors: Torsten Bohn; Charles Desmarchelier; Lars O Dragsted; Charlotte S Nielsen; Wilhelm Stahl; Ralph Rühl; Jaap Keijer; Patrick Borel Journal: Mol Nutr Food Res Date: 2017-02-27 Impact factor: 5.914
Authors: V Marcil; D Sinnett; E Seidman; F Boudreau; F-P Gendron; J-F Beaulieu; D Menard; M Lambert; A Bitton; R Sanchez; D Amre; E Levy Journal: Genes Immun Date: 2012-08-23 Impact factor: 2.676